Clinical Chemistry and Laboratory Medicine (CCLM)
Human health risk assessment of antibiotic resistance associated with antibiotic residues in the environment: A review - ScienceDirect
Integrating genetic and epigenetic factors in chronic myeloid leukemia risk assessment: toward gene expression-based biomarkers | Haematologica
Frontiers | The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19 | Immunology
Biological Risk Assessment: General Considerations for Laboratories
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium - Annals of Oncology
Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Therapeutics and Clinical Risk Management - Dove Press
Therapeutics and Clinical Risk Management - Dove Press
Stages of development of gene expression-based biomarkers. In chronic... | Download Scientific Diagram
Clinical & Experimental Immunology - Wiley Online Library
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study - ScienceDirect
Machine learning approach to dynamic risk modeling of mortality in COVID-19: a UK Biobank study | Scientific Reports
Therapeutics and Clinical Risk Management | Volume 12 - Dove Press
Therapeutics and Clinical Risk Management – ScienceOpen
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 | NEJM
Nonhospitalized Adults: Therapeutic Management | COVID-19 Treatment Guidelines
The Impact of Sickle Cell Disease: Updates in Therapeutics, Treatment, Management, and Future Directions - European Medical Journal
Therapeutics and Clinical Risk Management | Volume 14 - Dove Press
Archive of "Therapeutics and Clinical Risk Management". - PMC
Hospitalized Adults: Therapeutic Management | COVID-19 Treatment Guidelines
Therapeutics and Clinical Risk Management | Volume 14 - Dove Press
5 Successful Risk Scoring Tips to Improve Predictive Analytics
Using Risk Scores, Stratification for Population Health Management
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients | NEJM
